Skip to main content
. Author manuscript; available in PMC: 2009 Sep 16.
Published in final edited form as: J Mol Cell Cardiol. 2007 Aug 1;43(4):445–454. doi: 10.1016/j.yjmcc.2007.07.058

Figure 5.

Figure 5

Cardiac hypertrophy in SUR2 null mice. A. Representative photomicrographs of hemotoxylin and eosin and Masson trichrome stained sections from control and SUR2 null hearts. Despite significant increases in heart size, SUR2 null hearts exhibited no fibrosis, cardiomyocyte disarray or other structural defects. (Scale bar = 0.5 mm) B. Hearts from SUR2 null mice are significantly larger than matched control hearts as measured by ventricular weight or relative heart size (ventricular weight/body weight, gm/gm). * p<0.05, n=16 and n=20 for control and SUR2 null cohorts, respectively. C. Average body weight of the control and SUR2 null cohorts were not significantly different.

HHS Vulnerability Disclosure